MedTrace Logo

Metabolic Syndrome Feasibility Study

NCT02287766 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 193

Last updated 2015-08-04

No results posted yet for this study

Summary

The objective of this study is to determine whether the finger tip images captured by the EPIC ClearView device, when analyzed via the ClearView software, produce a Response Scale that characterizes trends consistent with Metabolic Syndrome identified by medical doctors.

Conditions

  • Metabolic Syndrome

Sponsors & Collaborators

  • Epic Research & Diagnostics, Inc.

    lead INDUSTRY

Principal Investigators

  • Nancy R Rizzo, PhD · EPIC Research and Diagnostics

Eligibility

Min Age
21 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-11-30
Primary Completion
2015-06-30
Completion
2015-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02287766 on ClinicalTrials.gov